BIOMAT Database Logo BIOMAT Database Logo

Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1. 1994

H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Institute of Clinical Biochemistry, University of Oslo, Rikshospitalet, Norway.

In six unrelated patients with hereditary tyrosinemia type 1 (HT1), three different disease-causing mutations were found by DNA sequencing. Two Pakistani patients, with acute and intermediate forms of HT1, were homozygous for a G192-->T mutation in the last nucleotide of exon 2. This caused aberrant splicing with partial intron 2 retention and premature termination. Three Turkish patients with chronic and intermediate forms of HT1 were homozygous for an A698-->T mutation substituting aspartic acid 233 with valine. A Norwegian patient with an intermediate clinical phenotype was heterozygous for G786-->A, introducing a TGA stop codon for Trp262 (W262X). Site-directed mutagenesis and expression in a rabbit reticulocyte lysate system demonstrated that the nonsense and missense mutations abolished fumarylacetoacetase activity and gave reduced amounts of a truncated and a full-length protein, respectively. Simple tests were established to identify the three mutations by restriction digestion of PCR-amplified genomic DNA. Among 30 additional HT1 patients investigated, 2 were found to be homozygous and 1 heterozygous for G192-->T. Two other patients were homozygous and one was heterozygous for W262X.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006867 Hydrolases Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3. Hydrolase

Related Publications

H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.
January 1996, Human genetics,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Identification of a combined missense/splice-site mutation in FAH causing tyrosinemia type 1.
July 2014, Journal of pediatric endocrinology & metabolism : JPEM,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
A novel mutation causing mild, atypical fumarylacetoacetase deficiency (Tyrosinemia type I): a case report.
December 2009, Orphanet journal of rare diseases,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Novel missense MTTP gene mutations causing abetalipoproteinemia.
October 2014, Biochimica et biophysica acta,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1.
November 2012, European journal of medical genetics,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1.
May 2001, The Journal of biological chemistry,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
January 1997, Human mutation,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1.
January 2013, PloS one,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Mutation spectrum of fumarylacetoacetase gene and clinical aspects of tyrosinemia type I disease.
January 2011, JIMD reports,
H Rootwelt, and R Berger, and G Gray, and D A Kelly, and T Coşkun, and E A Kvittingen
Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
March 1998, Human genetics,
Copied contents to your clipboard!